Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS - ADVERSE EFFECTS , . Treffer: 93

2022

Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

2021

Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Piccolo, V; Corneli, P; Zalaudek, I; Argenziano, G; Conforti, C; Alfano, R; Russo, T Mees' lines because of chemotherapy for Hodgkin's lymphoma.
Int J Dermatol. 2020; 59(2):e38 Doi: 10.1111/ijd.14649 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2018

Gandhi, L; Rodríguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SY; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC; KEYNOTE-189 Investigators Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018; 378(22): 2078-2092. Doi: 10.1056/NEJMoa1801005
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

 

Hann, A; Bohle, W; Egger, J; Zoller, W Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer.
Sci Rep. 2017; 7(3): 41549-41549. Doi: 10.1038/srep41549 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, LC; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, AK; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol. 2016; 27(12):2236-2241 Doi: 10.1093/annonc/mdw418 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Aigner, B; Bauernhofer, T; Petru, E; Niederkorn, A; Arzberger, EJ; Richtig, E Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
Dermatology. 2014; 229(4):288-292 Doi: 10.1159/000365391 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Ediebah, DE; Coens, C; Zikos, E; Quinten, C; Ringash, J; King, MT; Schmucker von Koch, J; Gotay, C; Greimel, E; Flechtner, H; Weis, J; Reeve, BB; Smit, EF; Taphoorn, MJ; Bottomley, A Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Br J Cancer. 2014; 110(10):2427-2433 Doi: 10.1038/bjc.2014.208 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gilg, MM; Wibmer, C; Andreou, D; Avian, A; Sovinz, P; Maurer-Ertl, W; Tunn, PU; Leithner, A Paley's multiplier method does not accurately predict adult height in children with bone sarcoma.
Clin Orthop Relat Res. 2014; 472(8):2506-2513 Doi: 10.1007/s11999-014-3636-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Aigner, B; Plötz, SG; Schaller, G Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature.
Wien Med Wochenschr. 2013; 163(21-22): 495-498. Doi: 10.1007/s10354-013-0242-0 (- Case Report)
PubMed FullText FullText_MUG

 

Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Eur J Cancer. 2013; 49(2):352-359 Doi: 10.1016/j.ejca.2012.08.004
Web of Science PubMed FullText FullText_MUG

 

Müller, E; Seidel, MG; Lackner, H; Dworzak, M; Urban, C Acute promyelocytic leukemia complicated by massive intracerebral hemorrhage: safety and efficacy of replacing conventional chemotherapy with arsenic trioxide in an adolescent.
Klin Padiatr. 2013; 225(3):172-173 Doi: 10.1055/s-0033-1334898 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414 Doi: 10.1038/bjc.2013.114 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pichler, H; Reismüller, B; Steiner, M; Dworzak, MN; Pötschger, U; Urban, C; Meister, B; Schmitt, K; Panzer-Grümayer, R; Haas, OA; Attarbaschi, A; Mann, G; Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Br J Haematol. 2013; 161(4):556-565 Doi: 10.1111/bjh.12292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, M; Müllauer, L; Greil, R; Raderer, M Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Haematologica. 2013; 98(2):264-268 Doi: 10.3324/haematol.2012.072587 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2012; 30(7):722-728 Doi: 10.1200/JCO.2011.36.8993 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fassnacht, M; Terzolo, M; Allolio, B; Baudin, E; Haak, H; Berruti, A; Welin, S; Schade-Brittinger, C; Lacroix, A; Jarzab, B; Sorbye, H; Torpy, DJ; Stepan, V; Schteingart, DE; Arlt, W; Kroiss, M; Leboulleux, S; Sperone, P; Sundin, A; Hermsen, I; Hahner, S; Willenberg, HS; Tabarin, A; Quinkler, M; de la Fouchardire, C; Schlumberger, M; Mantero, F; Weismann, D; Beuschlein, F; Gelderblom, H; Wilmink, H; Sender, M; Edgerly, M; Kenn, W; Fojo, T; Müller, HH; Skogseid, B; FIRM-ACT Study Group Combination chemotherapy in advanced adrenocortical carcinoma.
N Engl J Med. 2012; 366(23):2189-2197 Doi: 10.1056/NEJMoa1200966 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jahnel, J; Lackner, H; Reiterer, F; Urlesberger, B; Urban, C Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Klin Padiatr. 2012; 224(6):395-397 Doi: 10.1055/s-0032-1323823 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Partl, R; Richtig, E; Kapp, KS Calling attention to radiation recall reactions. Simultaneous occurrence of a Recall Dermatitis after CMF application in two separate sites irradiated 10 years apart.
Acta Oncol. 2012; 51(6):809-811 Doi: 10.3109/0284186X.2011.639799 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Eisterer, W; Hussl, C; Erb, H; Haslbauer, F; Sormann, S; Braun, S; Jaeger, C RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy.
Curr Med Res Opin. 2011; 27(2):355-363 Doi: 10.1185/03007995.2010.542134
Web of Science PubMed FullText FullText_MUG

 

Greimel, ER; Bjelic-Radisic, V; Pfisterer, J; Hilpert, F; Daghofer, F; Pujade-Lauraine, E; du Bois, A; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR); Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire (GINECO) Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.
Support Care Cancer. 2011; 19(9):1421-1427 Doi: 10.1007/s00520-010-0969-8
Web of Science PubMed FullText FullText_MUG

 

Kurtz, JE; Kaminsky, MC; Floquet, A; Veillard, AS; Kimmig, R; Dorum, A; Elit, L; Buck, M; Petru, E; Reed, N; Scambia, G; Varsellona, N; Brown, C; Pujade-Lauraine, E; on behalf of Gynecologic Cancer Intergroup Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
ANN ONCOL. 2011; 22(11): 2417-2423. Doi: 10.1093/annonc/mdr001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lee, CK; Gurney, H; Brown, C; Sorio, R; Donadello, N; Tulunay, G; Meier, W; Bacon, M; Maenpaa, J; Petru, E; Reed, N; Gebski, V; Pujade-Lauraine, E; Lord, S; Simes, RJ; Friedlander, M Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
BRIT J CANCER. 2011; 105(3): 360-365. Doi: 10.1038/bjc.2011.256 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Mlineritsch, B; Schabel-Moser, R; Andel, J; Fridrik, M; Moik, M; Mayer, P; Russ, G; Rass, C; Greil, R; Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Onkologie. 2009; 32(1-2):18-24 Doi: 10.1159/000180915
Web of Science PubMed FullText FullText_MUG

 

2008

Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087 Doi: 10.1158/1078-0432.CCR-07-2068 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Lackner, H; Urban, C; Sovinz, P; Benesch, M; Moser, A; Schwinger, W Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children.
Haematologica. 2008; 93(2): 291-294. Doi: 10.3324/haematol.11704 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leyvraz, S; Pampallona, S; Martinelli, G; Ploner, F; Perey, L; Aversa, S; Peters, S; Brunsvig, P; Montes, A; Lange, A; Yilmaz, U; Rosti, G; Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
J Natl Cancer Inst. 2008; 100(8): 533-541. Doi: 10.1093/jnci/djn088 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schmid, P; Kühnhardt, D; Kiewe, P; Lehenbauer-Dehm, S; Schippinger, W; Greil, R; Lange, W; Preiss, J; Niederle, N; Brossart, P; Freier, W; Kümmel, S; Van de Velde, H; Regierer, A; Possinger, K A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
Ann Oncol. 2008; 19(5):871-876 Doi: 10.1093/annonc/mdm569 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Spieth, K; Kaufmann, R; Dummer, R; Garbe, C; Becker, JC; Hauschild, A; Tilgen, W; Ugurel, S; Beyeler, M; Bröcker, EB; Kaehler, KC; Pföhler, C; Gille, J; Leiter, U; Schadendorf, D Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Ann Oncol. 2008; 19(4):801-806 Doi: 10.1093/annonc/mdm565 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Bader, AA; Schlembach, D; Tamussino, KF; Pristauz, G; Petru, E Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Lancet Oncol. 2007; 8(1):79-81 Doi: 10.1016/S1470-2045(06)71014-2 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Dawood, S; Gonzalez-Angulo, AM; Peintinger, F; Broglio, K; Symmans, WF; Kau, SW; Islam, R; Hortobagyi, GN; Buzdar, AU Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
Cancer. 2007; 110(6): 1195-1200. Doi: 10.1002/cncr.22895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hilpert, F; du Bois, A; Greimel, E; Hedderich, J; Krause, G; Venhoff, L; Loibl, S; Pfisterer, J Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany.
Ann Oncol. 2007; 18(2): 282-287. Doi: 10.1093/annonc/mdl401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krappmann, P; Paulides, M; Stöhr, W; Ittner, E; Plattig, B; Nickel, P; Lackner, H; Schrappe, M; Janka, G; Beck, JD; Langer, T Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Pediatr Hematol Oncol. 2007; 24(2):101-109 Doi: 10.1080/08880010601123281
Web of Science PubMed FullText FullText_MUG

 

2006

Greimel, ER; Bjelic-Radisic, V; Pfisterer, J; Hilpert, F; Daghofer, F; du Bois, A; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
J CLIN ONCOL. 2006; 24(4): 579-586. Doi: 10.1200/JCO.2005.02.4067 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Petru, E; Angleitner-Boubenizek, L; Reinthaller, A; Deibl, M; Zeimet, AG; Volgger, B; Stempfl, A; Marth, C Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study.
Gynecol Oncol. 2006; 102(2):226-229 Doi: 10.1016/j.ygyno.2005.12.017
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293 Doi: 10.1159/000094890
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Strenger, V; Lackner, H; Dornbusch, HJ; Beham-Schmid, C; Urban, C Images in haematology. Cervical mass after cytotoxic chemotherapy, secondary malignancy or epiphenomenon?
Br J Haematol. 2006; 135(1):1-1 Doi: 10.1111/j.1365-2141.2006.06189.x (- Case Report)
PubMed FullText FullText_MUG

 

Ugurel, S; Schadendorf, D; Pföhler, C; Neuber, K; Thoelke, A; Ulrich, J; Hauschild, A; Spieth, K; Kaatz, M; Rittgen, W; Delorme, S; Tilgen, W; Reinhold, U; Dermatologic Cooperative Oncology Group In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
Clin Cancer Res. 2006; 12(18):5454-5463 Doi: 10.1158/1078-0432.CCR-05-2763 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Petru, E; Petru, C; Benedicic, Ch Re: Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
GYNECOL ONCOL. 2005; 96(2): 559; author reply 559-559; author reply 560. Doi: 10.1016/j.ygyno.2004.09.060
Web of Science PubMed FullText FullText_MUG

 

Pico, JL; Rosti, G; Kramar, A; Wandt, H; Koza, V; Salvioni, R; Theodore, C; Lelli, G; Siegert, W; Horwich, A; Marangolo, M; Linkesch, W; Pizzocaro, G; Schmoll, HJ; Bouzy, J; Droz, JP; Biron, P; Genito-Urinary Group of the French Federation of Cancer Centers (GETUG-FNCLCC), France; European Group for Blood and Marrow Transplantation (EBMT) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Ann Oncol. 2005; 16(7):1152-1159 Doi: 10.1093/annonc/mdi228 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Glaus, A; Knipping, C; Morant, R; Böhme, C; Lebert, B; Beldermann, F; Glawogger, B; Ortega, PF; Hüsler, A; Deuson, R Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.
Support Care Cancer. 2004; 12(10):708-715 Doi: 10.1007/s00520-004-0662-x
Web of Science PubMed FullText FullText_MUG

 

Rosset, L; Toetsch, M; Kaiser, L; Helg, C Isolated subcutaneous cryptococcal abscess after a BEACOPP regimen for Hodgkin's lymphoma
EUR J CLIN MICROBIOL INFECT D. 2004; 23(7): 578-579. Doi: 10.1007/s10096-004-1157-x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2003

Bauernhofer, T; Eibl, M; Ploner, F; Kuss, I; Pfeifer, J; Sill, H; Samonigg, H Acute pseudo-obstruction of the small intestine following high-dose chemotherapy and stem cell support.
Onkologie. 2003; 26(4):344-346 Doi: 10.1159/000072093 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Dalpiaz, O; al Rabi, N; Galfano, A; Martignoni, G; Ficarra, V; Artibani, W Small cell carcinoma of the bladder: a case report and a literature review.
Arch Esp Urol. 2003; 56(2):197-202 (- Case Report)
PubMed

 

Denison, U; Baumann, J; Peters-Engl, C; Samonigg, H; Krippl, P; Lang, A; Obermair, A; Wagner, H; Sevelda, P Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.
Breast Cancer Res Treat. 2003; 79(3):347-353 Doi: 10.1023/A:1024016508925
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Green, MD; Koelbl, H; Baselga, J; Galid, A; Guillem, V; Gascon, P; Siena, S; Lalisang, RI; Samonigg, H; Clemens, MR; Zani, V; Liang, BC; Renwick, J; Piccart, MJ; International Pegfilgrastim 749 Study Group A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.
Ann Oncol. 2003; 14(1):29-35 Doi: 10.1093/annonc/mdg019 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum